School of Medicine & Pharmacology M503, Sir Charles Gairdner Hospital Unit, University of Western Australia, Crawley, Western Australia, Australia.
J Am Heart Assoc. 2013 Oct 8;2(5):e000172. doi: 10.1161/JAHA.113.000172.
Advances in treatment for acute myocardial infarction (AMI) are likely to have had a beneficial impact on the incidence of and deaths attributable to heart failure (HF) complicating AMI, although limited data are available to support this contention.
Western Australian linked administrative health data were used to identify 20 812 consecutive patients, aged 40 to 84 years, without prior HF hospitalized with an index (first) AMI between 1996 and 2007. We assessed the temporal incidence of and adjusted odds ratio/hazard ratio for death associated with HF concurrent with AMI admission and within 1 year after discharge. Concurrent HF comprised 75% of incident HF cases. Between the periods 1996-1998 and 2005-2007, the prevalence of HF after AMI declined from 28.1% to 16.5%, with an adjusted odds ratio of 0.50 (95% CI, 0.44 to 0.55). The crude 28-day case-fatality rate for patients with concurrent HF declined marginally from 20.5% to 15.9% (P < 0.05) compared with those without concurrent HF, in whom the case-fatality rate declined from 11.0% to 4.8% (P < 0.001). Concurrent HF was associated with a multivariate-adjusted odds ratio of 2.2 for 28-day mortality and a hazard ratio of 2.2 for 1-year mortality in 28-day survivors. Occurrence of HF within 90 days of the index AMI was associated with an adjusted hazard ratio of 2.7 for 1-year mortality in 90-day survivors.
Despite encouraging declines in the incidence of HF complicating AMI, it remains a common problem with high mortality. Increased attention to these high-risk patients is needed given the lack of improvement in their long-term prognosis.
急性心肌梗死(AMI)治疗的进步可能对 AMI 并发心力衰竭(HF)的发病率和死亡率产生了有益的影响,尽管目前的数据有限,但支持这一观点。
我们使用西澳大利亚州的链接行政健康数据,确定了 20812 例连续患者,年龄在 40 至 84 岁之间,在 1996 年至 2007 年期间没有预先存在的 HF 住院,诊断为首次 AMI。我们评估了 AMI 入院时和出院后 1 年内并发 HF 的时间发生率和调整后的比值比/风险比与 AMI 入院时并发 HF 相关的死亡。并发 HF 占所有 HF 病例的 75%。在 1996-1998 年和 2005-2007 年期间,AMI 后 HF 的患病率从 28.1%下降到 16.5%,调整后的比值比为 0.50(95%CI,0.44 至 0.55)。并发 HF 患者的 28 天病死率从 20.5%略微下降到 15.9%(P<0.05),而无并发 HF 的患者从 11.0%下降到 4.8%(P<0.001)。在 28 天存活者中,并发 HF 与 28 天死亡率的多变量调整比值比为 2.2,与 1 年死亡率的风险比为 2.2。在指数 AMI 后 90 天内发生 HF 与 90 天存活者的 1 年死亡率的调整后风险比为 2.7 相关。
尽管 AMI 并发 HF 的发病率令人鼓舞地下降,但它仍然是一个常见的问题,死亡率很高。鉴于这些高危患者的长期预后没有改善,需要对他们给予更多关注。